159 research outputs found
Validation of a model to predict adverse outcomes in patients with pulmonary embolism.
AIMS: To validate a model for quantifying the prognosis of patients with pulmonary embolism (PE). The model was previously derived from 10 534 US patients. METHODS AND RESULTS: We validated the model in 367 patients prospectively diagnosed with PE at 117 European emergency departments. We used baseline data for the model's 11 prognostic variables to stratify patients into five risk classes (I-V). We compared 90-day mortality within each risk class and the area under the receiver operating characteristic curve between the validation and the original derivation samples. We also assessed the rate of recurrent venous thrombo-embolism and major bleeding within each risk class. Mortality was 0% in Risk Class I, 1.0% in Class II, 3.1% in Class III, 10.4% in Class IV, and 24.4% in Class V and did not differ between the validation and the original derivation samples. The area under the curve was larger in the validation sample (0.87 vs. 0.78, P=0.01). No patients in Classes I and II developed recurrent thrombo-embolism or major bleeding. CONCLUSION: The model accurately stratifies patients with PE into categories of increasing risk of mortality and other relevant complications. Patients in Risk Classes I and II are at low risk of adverse outcomes and are potential candidates for outpatient treatment
Characterisation of metabolites of the putative cancer chemopreventive agent quercetin and their effect on cyclo-oxygenase activity
Quercetin (3,5,7,3âČ,4âČ-pentahydroxyflavone) is a flavone with putative ability to prevent cancer and cardiovascular diseases. Its metabolism was evaluated in rats and human. Rats received quercetin via the intravenous (i.v.) route and metabolites were isolated from the plasma, urine and bile. Analysis was by high-performance liquid chromatography and confirmation of species identity was achieved by mass spectrometry. Quercetin and isorhamnetin, the 3âČ-O-methyl analogue, were found in both the plasma and urine. In addition, several polar peaks were characterised as sulphated and glucuronidated conjugates of quercetin and isorhamnetin. Extension of the metabolism studies to a cancer patient who had received quercetin as an i.v. bolus showed that (Quercetin removed) isorhamnetin and quercetin 3âČ-O-sulphate were major plasma metabolites. As a catechol, quercetin can potentially be converted to a quinone and subsequently conjugated with glutathione (GSH). Oxidation of quercetin with mushroom tyrosinase in the presence of GSH furnished GSH conjugates of quercetin, two mono- and one bis-substituted conjugates. However, these species were not found in biomatrices in rats treated with quercetin. As cyclo-oxygenase-2 (COX-2) expression is mechanistically linked to carcinogenesis, we examined whether quercetin and its metabolites can inhibit COX-2 in a human colorectal cancer cell line (HCA-7). Isorhamnetin and its 4âČ-isomer tamarixetin were potent inhibitors, reflected in a 90% decrease in prostaglandin E-2 (PGE-2) levels, a marker of COX-2 activity. Quercetin was less effective, with a 50% decline. Quercetin 3- and 7-O-sulphate had no effect on PGE-2. The results indicate that quercetin may exert its pharmacological effects, at least in part, via its metabolites
The risk of lung cancer related to dietary intake of flavonoids
It has been hypothesized that flavonoids in foods and beverages may reduce cancer risk through
antioxidation, inhibition of inflammation, and other antimutagenic and antiproliferative
properties. We examined associations between intake of five flavonoid subclasses
(anthocyanidins, flavan-3-ols, flavones, flavonols, flavanones) and lung cancer risk in a
population-based case-control study in Montreal, Canada (1,061 cases and 1,425 controls).
Flavonoid intake was estimated from a food frequency questionnaire that assessed diet two years
prior to diagnosis (cases) or interview (controls). Odds ratios (ORs) and 95% confidence
intervals (CIs) were estimated using unconditional logistic regression. Overall, total flavonoid
intake was not associated with lung cancer risk, the effect being similar regardless of sex and
smoking level. However, low flavonoid intake from food, but not from beverages, was
associated with an increased risk. The adjusted ORs (95% CIs) comparing the highest versus the
lowest quartiles of intake were 0.63 (0.47-0.85) for total flavonoids, 0.82 (0.61-1.11) for
anthocyanidins, 0.67 (0.50-0.90) for flavan-3-ols, 0.68 (0.50-0.93) for flavones, 0.62 (0.45-0.84)
for flavonols, and 0.70 (0.53-0.94) for flavanones. An inverse association with total flavone and
flavanone intake was observed for squamous cell carcinoma but not adenocarcinoma. In
conclusion, low flavonoid intake from food may increase lung cancer risk
Lactic acid fermentation as a tool to enhance the antioxidant properties of Myrtus communis berries
Background: Myrtle (Myrtus communis L.) is a medicinal and aromatic plant belonging to Myrtaceae family, which
is largely diffused in the Mediterranean areas and mainly cultivated in Tunisia and Italy. To the best of our knowledge, no
studies have already considered the use of the lactic acid fermentation to enhance the functional features of M.
communis. This study aimed at using a selected lactic acid bacterium for increasing the antioxidant features of myrtle
berries, with the perspective of producing a functional ingredient, dietary supplement or pharmaceutical preparation.
The antioxidant activity was preliminarily evaluated through in vitro assays, further confirmed through ex vivo analysis on
murine fibroblasts, and the profile of phenol compounds was characterized.
Results: Myrtle berries homogenate, containing yeast extract (0.4%, wt/vol), was fermented with Lactobacillus plantarum
C2, previously selected from plant matrix. Chemically acidified homogenate, without bacterial inoculum and incubated
under the same conditions, was used as the control. Compared to the control, fermented myrtle homogenate exhibited
a marked antioxidant activity in vitro. The radical scavenging activity towards DPPH increased by 30%, and the
inhibition of linoleic acid peroxidation was twice. The increased antioxidant activity was confirmed using Balb 3 T3
mouse fibroblasts, after inducing oxidative stress, and determining cell viability and radical scavenging activity
through MTT and DCFH-DA assays, respectively. The lactic acid fermentation allowed increased concentrations of total
phenols, flavonoids and anthocyanins, which were 5â10 times higher than those found for the non-fermented and
chemically acidified control. As shown by HPLC analysis, the main increases were found for gallic and ellagic acids, and
flavonols (myricetin and quercetin). The release of these antioxidant compounds would be strictly related to the
esterase activities of L. plantarum.
Conclusions: The lactic acid fermentation of myrtle berries is a suitable tool for novel applications as functional
food dietary supplements or pharmaceutical preparations
Perioperative echocardiography-guided hemodynamic therapy in high-risk patients:a practical expert approach of hemodynamically focused echocardiography
The number of high-risk patients undergoing surgery is growing. To maintain adequate hemodynamic functioning as well as oxygen delivery to the vital organs (DO2) amongst this patient population, a rapid assessment of cardiac functioning is essential for the anesthesiologist. Pinpointing any underlying cardiovascular pathophysiology can be decisive to guide interventions in the intraoperative setting. Various techniques are available to monitor the hemodynamic status of the patient, however due to intrinsic limitations, many of these methods may not be able to directly identify the underlying cause of cardiovascular impairment. Hemodynamic focused echocardiography, as a rapid diagnostic method, offers an excellent opportunity to examine signs of filling impairment, cardiac preload, myocardial contractility and the function of the heart valves. We thus propose a 6-step-echocardiographic approach to assess high-risk patients in order to improve and maintain perioperative DO2. The summary of all echocardiographic based findings allows a differentiated assessment of the patient's cardiovascular function and can thus help guide a (patho)physiological-orientated and individualized hemodynamic therapy
Recommended from our members
Gut microbiota functions: metabolism of nutrients and other food components
The diverse microbial community that inhabits the human gut has an extensive metabolic repertoire that is distinct from, but complements the activity of mammalian enzymes in the liver and gut mucosa and includes functions essential for host digestion. As such, the gut microbiota is a key factor in shaping the biochemical profile of the diet and, therefore, its impact on host health and disease. The important role that the gut microbiota appears to play in human metabolism and health has stimulated research into the identification of specific microorganisms involved in different processes, and the elucidation of metabolic pathways, particularly those associated with metabolism of dietary components and some host-generated substances. In the first part of the review, we discuss the main gut microorganisms, particularly bacteria, and microbial pathways associated with the metabolism of dietary carbohydrates (to short chain fatty acids and gases), proteins, plant polyphenols, bile acids, and vitamins. The second part of the review focuses on the methodologies, existing and novel, that can be employed to explore gut microbial pathways of metabolism. These include mathematical models, omics techniques, isolated microbes, and enzyme assays
Erratum to: Methods for evaluating medical tests and biomarkers
[This corrects the article DOI: 10.1186/s41512-016-0001-y.]
Recommended from our members
Destructive fishing: An expert-driven definition and exploration of this quasi-concept
Data availability statement:
Data that breaches the anonymity of responses in this study cannot be made available. Some anonymised and summary data can be found in the Supplementary Information.Data Availability Statement: Data that breaches the anonymity of responses in this study cannot be made available. Some anonymized and summary data can be found in the Supplementary Information.Code Availability Statement: Code for the figures and certain analyses used in this manuscript can be found at https://github.com/arlie-m/destructive_fishing_defintion_delphi.Supporting Information is available online at: https://conbio.onlinelibrary.wiley.com/doi/10.1111/conl.13015#support-information-section .Numerous policy and international frameworks consider that âdestructive fishingâ hampers efforts to reach sustainability goals. Though ubiquitous, âdestructive fishingâ is undefined and therefore currently immeasurable. Here we propose a definition developed through expert consultation: âDestructive fishing is any fishing practice that causes irrecoverable habitat degradation, or which causes significant adverse environmental impacts, results in long-term declines in target or nontarget species beyond biologically safe limits and has negative livelihood impacts.â We show strong stakeholder support for a definition, consensus on many biological and ecological dimensions, and no clustering of respondents from different sectors. Our consensus definition is a significant step toward defining sustainable fisheries goals and will help interpret and implement global political commitments which utilize the term âdestructive fishing.â Our definition and results will help reinforce the Food and Agricultural Organization's Code of Conduct and meaningfully support member countries to prohibit destructive fishing practices.Cambridge Conservation Initiative. Grant Number: CCI-05-20-009;
Helmholtz Institute for Functional Marine Biodiversity (HIFMB) at the University of Oldenburg;
Brunel University London;
Alfred-Wegener-Institute for Polar and Marine Research;
Arcadia;
Rothschild Foundation;
A.G. Leventis Foundation;
Isaac Newton Trust;
Prince Albert II of Monaco Foundation
- âŠ